| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-09 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-09 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
9e-08 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-07 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-07 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
1e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
1e-05 |